Bank of Montreal
EIDX

Bank of Montreal’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bank of Montreal’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,145
Closed -$271K – 5505
2020
Q4 		$271K Buy
2,145
+1,191
+125% +$105K ﹤0.01% 3055
2020
Q3 		$70K Sell
954
-367
-28% -$16.5K ﹤0.01% 3272
2020
Q2 		$65K Buy
1,321
+871
+194% +$40.5K ﹤0.01% 3302
2020
Q1 		$19K Sell
450
-1,419
-76% -$72.3K ﹤0.01% 3280
2019
Q4 		$107K Buy
1,869
+449
+32% +$22.2K ﹤0.01% 3463
2019
Q3 		$51K Buy
1,420
+35
+3% +$1.37K ﹤0.01% 3618
2019
Q2 		$43K Buy
1,385
+835
+152% +$22.6K ﹤0.01% 3775
2019
Q1 		$13K Buy
550
+447
+434% +$7.17K ﹤0.01% 3807
2018
Q4 		$1K Buy
103
+53
+106% +$669 ﹤0.01% 4604
2018
Q3 		$0 Buy
+50
New +$822 ﹤0.01% 4970

Bank of Montreal's EIDX Position: Q1 2021 in Review

Bank of Montreal sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 2,145 shares — an estimated $271K sold.

Bank of Montreal first reported a position in EIDX in Q3 2018 and held it in 10 quarters. The position peaked at $271K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Bank of Montreal reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,145 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $271K.
  • Bank of Montreal first reported a position in Eidos Therapeutics, Inc. Common Stock in Q3 2018 and held it in 10 quarters.
  • Bank of Montreal's Eidos Therapeutics, Inc. Common Stock position peaked at $271K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Bank of Montreal's 13F filing for Q1 2021, filed 13 May 2021.